Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Ravindra Kumar. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Ravindra Kumar har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:XLRN / Acceleron Pharma Inc | SVP & Chief Scientific Officer | 86 986 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Ravindra Kumar. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Ravindra Kumar som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 389 | 86 986 | −3,75 | 45,24 | −153 318 | 3 935 247 |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −70 | 90 375 | −0,08 | 44,24 | −3 097 | 3 998 190 |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 90 445 | −0,11 | 45,46 | −4 546 | 4 111 630 |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 452 | 90 545 | −3,67 | 44,62 | −154 028 | 4 040 118 |
| 2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 21 500 | 21 500 | |||||
| 2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 3 850 | 93 997 | 4,27 | ||||
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −374 | 90 147 | −0,41 | 43,94 | −16 434 | 3 961 059 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 051 | 90 521 | −3,26 | 43,20 | −131 803 | 3 910 507 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 363 | 93 572 | −2,46 | 42,45 | −100 309 | 3 972 131 |
| 2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 95 935 | −0,10 | 39,16 | −3 916 | 3 756 815 |
| 2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 103 | 96 035 | −1,14 | 38,34 | −42 289 | 3 681 982 |
| 2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 26 775 | 26 775 | |||||
| 2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 463 | 97 138 | 4,82 | ||||
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 300 | 92 675 | −4,43 | 42,41 | −182 363 | 3 930 347 |
| 2017-09-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −6 761 | 0 | −100,00 | ||||
| 2017-09-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 761 | 96 975 | 7,49 | 5,28 | 35 698 | 512 028 | |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −8 | 90 214 | −0,01 | 38,12 | −305 | 3 438 958 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 90 222 | −0,55 | 39,39 | −19 695 | 3 553 845 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 605 | 90 722 | −4,83 | 38,31 | −176 418 | 3 475 560 |
| 2017-08-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −13 065 | 3 624 | −78,29 | |||
| 2017-08-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −13 065 | 95 327 | −12,05 | 35,41 | −462 632 | 3 375 529 |
| 2017-08-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 13 065 | 108 392 | 13,71 | 24,11 | 314 997 | 2 613 331 |
| 2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −937 | 0 | −100,00 | |||
| 2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −937 | 95 327 | −0,97 | 32,00 | −29 984 | 3 050 464 |
| 2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 937 | 96 264 | 0,98 | 7,12 | 6 671 | 685 400 |
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 300 | 41 300 | |||||
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 900 | 95 327 | 7,80 | ||||
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 641 | 88 427 | −1,82 | 27,60 | −45 292 | 2 440 585 |
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −359 | 90 068 | −0,40 | 26,81 | −9 625 | 2 414 723 |
| 2016-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −4 561 | 0 | −100,00 | ||||
| 2016-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −10 000 | 6 761 | −59,66 | ||||
| 2016-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 4 561 | 90 427 | 5,31 | 3,88 | 17 697 | 350 857 | |
| 2016-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 85 866 | 13,18 | 5,28 | 52 800 | 453 372 | |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 550 | 31 850 | −12,50 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −8 101 | 16 689 | −32,68 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 182 | 937 | −81,70 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −16 833 | 75 866 | −18,16 | 34,14 | −574 679 | 2 590 065 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 550 | 92 699 | 5,16 | 27,97 | 127 264 | 2 592 791 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 8 101 | 88 149 | 10,12 | 24,11 | 195 315 | 2 125 272 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 182 | 80 048 | 5,51 | 7,12 | 29 776 | 569 942 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 210 | 24 790 | −14,52 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 381 | 5 119 | −31,75 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 115 | 16 761 | −6,24 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 984 | 0 | −100,00 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −954 | 4 561 | −17,30 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −28 | 75 866 | −0,04 | 34,00 | −952 | 2 579 444 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −19 616 | 75 894 | −20,54 | 33,37 | −654 586 | 2 532 583 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 210 | 95 510 | 4,61 | 24,11 | 101 503 | 2 302 746 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 381 | 91 300 | 2,68 | 7,12 | 16 953 | 650 056 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 115 | 88 919 | 1,27 | 5,28 | 5 887 | 469 492 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 984 | 87 804 | 14,30 | 5,28 | 57 996 | 463 605 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 954 | 76 820 | 1,26 | 3,88 | 3 702 | 298 062 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 124 | 17 876 | −28,50 | |||
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 561 | 75 866 | −2,02 | 34,98 | −54 604 | 2 653 793 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −14 448 | 77 427 | −15,73 | 34,31 | −495 711 | 2 656 520 |
| 2016-10-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 124 | 91 875 | 8,41 | 5,28 | 37 615 | 485 100 |
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 36 400 | 36 400 | |||||
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 000 | 84 751 | 7,62 | ||||
| 2016-02-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −8 000 | 5 515 | −59,19 | ||||
| 2016-02-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 8 000 | 78 751 | 11,31 | 3,88 | 31 040 | 305 554 | |
| 2015-10-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 516 | 10 984 | −33,43 | ||||
| 2015-10-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −6 250 | 0 | −100,00 | ||||
| 2015-10-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −2 300 | 0 | −100,00 | ||||
| 2015-10-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 516 | 70 751 | 8,46 | 5,28 | 29 124 | 373 565 | |
| 2015-10-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 250 | 65 235 | 10,60 | 5,08 | 31 750 | 331 394 | |
| 2015-10-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 2 300 | 58 985 | 4,06 | 1,80 | 4 140 | 106 173 | |
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −11 485 | 13 515 | −45,94 | |||
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −33 000 | 56 685 | −36,80 | 35,00 | −1 155 000 | 1 983 975 |
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 11 485 | 89 685 | 14,69 | 3,88 | 44 562 | 347 978 |
| 2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 40 000 | 78 200 | 104,71 | ||||
| 2015-04-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 2 300 | −68,49 | ||||
| 2015-04-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 38 200 | 15,06 | 1,80 | 9 000 | 68 760 | |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 0 | −100,00 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −500 | 0 | −100,00 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 33 200 | −0,30 | 42,04 | −4 204 | 1 395 728 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −366 | 33 300 | −1,09 | 41,09 | −15 039 | 1 368 297 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 034 | 33 666 | −2,98 | 40,62 | −42 001 | 1 367 513 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 34 700 | −0,86 | 42,06 | −12 618 | 1 459 482 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 614 | 35 000 | −4,41 | 41,22 | −66 529 | 1 442 700 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 086 | 36 614 | −5,39 | 40,56 | −84 608 | 1 485 064 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 500 | 38 700 | 9,94 | 5,88 | 20 580 | 227 556 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 500 | 35 200 | 1,44 | 5,88 | 2 940 | 206 976 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 500 | −88,89 | |||
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 34 700 | −0,86 | 39,46 | −11 838 | 1 369 262 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 200 | 35 000 | −3,31 | 38,56 | −46 272 | 1 349 600 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 435 | 36 200 | −3,81 | 39,13 | −56 152 | 1 416 506 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 565 | 37 635 | −6,38 | 38,39 | −98 470 | 1 444 808 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 40 200 | 11,05 | 5,88 | 23 520 | 236 376 |
| 2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 100 | 36 200 | −2,95 | 41,06 | −45 166 | 1 486 372 |
| 2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 37 300 | −1,06 | 40,09 | −16 036 | 1 495 357 |
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
| 2015-01-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 4 500 | −47,06 | |||
| 2015-01-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 37 700 | −1,05 | 39,37 | −15 748 | 1 484 249 |
| 2015-01-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 600 | 38 100 | −8,63 | 38,36 | −138 096 | 1 461 516 |
| 2015-01-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 41 700 | 10,61 | 5,88 | 23 520 | 245 196 |
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 825 | 7 300 | −44,38 | ||||
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −3 985 | 0 | −100,00 | ||||
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 825 | 37 700 | 18,27 | 1,80 | 10 485 | 67 860 | |
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 3 985 | 31 875 | 14,29 | 0,92 | 3 666 | 29 325 | |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 8 500 | −32,00 | |||
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 100 | 27 890 | −3,79 | 37,44 | −41 184 | 1 044 202 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 28 990 | −3,33 | 36,10 | −36 100 | 1 046 539 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 900 | 29 990 | −5,96 | 34,87 | −66 253 | 1 045 751 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 31 890 | 14,34 | 5,88 | 23 520 | 187 513 |
| 2014-12-02 |
|
4/A | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 20 500 | −8,89 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 16 500 | −23,26 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 16 500 | −23,26 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −12 000 | 27 890 | −30,08 | 35,00 | −420 000 | 976 150 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 39 890 | 14,33 | 5,28 | 26 400 | 210 619 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 34 890 | 16,73 | 5,88 | 29 400 | 205 153 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 14 500 | −21,62 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 400 | 29 890 | −7,43 | 33,56 | −80 544 | 1 003 108 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 32 290 | −4,72 | 32,46 | −51 936 | 1 048 133 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 33 890 | 13,38 | 5,88 | 23 520 | 199 273 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 18 500 | −17,78 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −608 | 29 890 | −1,99 | 30,36 | −18 459 | 907 460 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 392 | 30 498 | −10,01 | 29,57 | −100 301 | 901 826 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 33 890 | 13,38 | 5,88 | 23 520 | 199 273 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 21 500 | −14,00 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 6 500 | −18,75 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 000 | 29 890 | −18,98 | 30,00 | −210 000 | 896 700 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 500 | 36 890 | 10,48 | 5,28 | 18 480 | 194 779 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 33 390 | 4,70 | 5,88 | 8 820 | 196 333 |
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 8 000 | −20,00 | |||
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 31 890 | −5,90 | 26,40 | −52 800 | 841 896 |
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 33 890 | 6,27 | 5,88 | 11 760 | 199 273 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 10 000 | −33,33 | 5,88 | −29 400 | 58 800 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 000 | 31 890 | −18,00 | 30,00 | −210 000 | 956 700 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 38 890 | 14,75 | 5,88 | 29 400 | 228 673 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 33 890 | −5,57 | 29,85 | −59 700 | 1 011 616 |
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 35 890 | −5,28 | 34,10 | −68 200 | 1 223 849 |
| 2014-06-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 15 000 | −25,00 | |||
| 2014-06-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 000 | 37 890 | −15,59 | 35,00 | −245 000 | 1 326 150 |
| 2014-06-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 44 890 | 12,53 | 5,88 | 29 400 | 263 953 |
| 2014-06-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 39 890 | −4,77 | 29,72 | −59 440 | 1 185 531 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 20 000 | −20,00 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 41 890 | −0,48 | 32,27 | −6 454 | 1 351 790 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 800 | 42 090 | −4,10 | 31,51 | −56 718 | 1 326 256 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 43 890 | −1,13 | 32,13 | −16 065 | 1 410 186 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 500 | 44 390 | −12,77 | 31,23 | −202 995 | 1 386 300 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 50 890 | 10,90 | 5,88 | 29 400 | 299 233 |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 45 890 | −4,18 | 35,86 | −71 720 | 1 645 615 |
| 2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 | |||||
| 2013-09-18 | 3 | XLRN |
ACCELERON PHARMA INC
Common Stock |
47 890 |